What is LinkDoc?
Founded in 2014 and headquartered in Beijing, LinkDoc operates at the intersection of oncology and big data analytics. The company specializes in creating sophisticated medical data solutions that transform unstructured clinical information into structured, usable datasets. By partnering with tumor specialist hospitals and comprehensive tertiary institutions, LinkDoc facilitates improved clinical decision-making and research capabilities. Its platform serves as a vital bridge between raw medical records and the high-precision requirements of modern oncology, positioning the company as a key infrastructure provider in the digital health ecosystem.
How much funding has LinkDoc raised?
LinkDoc has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2015): $10M with participation from New Enterprise Associates
Key Investors in LinkDoc
New Enterprise Associates
Established in 1977 and headquartered in Menlo Park, California, New Enterprise Associates is a global venture capital firm focused on helping entrepreneurs build transformative businesses across multiple stages of growth.
What's next for LinkDoc?
With the current enterprise-level funding, LinkDoc is well-positioned to accelerate its product roadmap and deepen its integration within the Chinese healthcare market. The strategic focus will likely shift toward enhancing the interoperability of its tumor big data platforms and expanding its reach into additional clinical specialties. By prioritizing the refinement of its data processing algorithms, the company aims to set a new standard for clinical efficiency and patient outcomes. Future growth will depend on the firm's ability to maintain data integrity while scaling its infrastructure to meet the increasing volume of complex medical information generated by its hospital partners.
See full LinkDoc company page
